{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:44:17Z","timestamp":1793681057483,"version":"4.5.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/jcp.0b013e31815a4400","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T01:27:58Z","timestamp":1236216478000},"page":"620-624","source":"Crossref","is-referenced-by-count":29,"title":["12-Month Follow-Up Study of Drug Treatment in Pathological Gamblers"],"prefix":"10.1097","volume":"27","author":[{"given":"Pinhas N.","family":"Dannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lowengrub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Musin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehudit","family":"Gonopolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","article-title":"Estimating the prevalence of disorder gambling behavior in the United States and Canada: a research synthesis.","volume":"89","author":"Shaffer","year":"1999","journal-title":"Am J Public Health"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0193-953X(05)70185-4","article-title":"Pathological gambling.","volume":"23","author":"Hollander","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-0179-1-21","article-title":"Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review.","volume":"1","author":"Dell'Osso","year":"2005","journal-title":"Clin Pract Epidemol Ment Health"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathologic gambling.","volume":"47","author":"Hollander","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.","volume":"63","author":"Kim","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling.","volume":"14","author":"Blanco","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000073881.93678.21","article-title":"Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial.","volume":"18","author":"Grant","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.","volume":"49","author":"Kim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","article-title":"An open naltrexone treatment study in pathological gambling disorder.","volume":"16","author":"Kim","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.jcp.0000186867.90289.ed","article-title":"Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.","volume":"25","author":"Dannon","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","article-title":"Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.","volume":"28","author":"Dannon","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","article-title":"An open-label trial of bupropion in the treatment of pathological gambling.","volume":"24","author":"Black","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2217\/14750708.2.5.753","article-title":"Sustained release bupropion in the treatment of SSRI nonresponder pathological gamblers: pilot study and review of the literature.","volume":"2","author":"Dannon","year":"2005","journal-title":"Therapy"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.","volume":"178","author":"Thase","year":"2001","journal-title":"Br J Psychiatry"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1352465800016830","article-title":"Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling.","volume":"24","author":"Echeburua","year":"1996","journal-title":"Behav Cognitive Psychother"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1037\/0022-006X.65.5.727","article-title":"Cognitive and behavioral treatment of pathological gambling: a controlled study.","volume":"65","author":"Sylvain","year":"1997","journal-title":"J Consult Clin Psychol"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.144.9.1184","article-title":"The South Oaks Gambling Screen (the SOGS): a new instrument for the identification of pathological gamblers.","volume":"144","author":"Lesieur","year":"1987","journal-title":"Am J Psychiatry"},{"issue":"suppl","key":"R21-11-20210128","first-page":"1","article-title":"Practice guidelines for the treatment of patients with panic disorder.","volume":"155","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1017\/S109285290001957X","article-title":"The impact of comorbidity on the management of pathological gambling.","volume":"10","author":"Dell'Osso","year":"2005","journal-title":"CNS Spectr"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1021227214142","article-title":"Advances in the pharmacological treatment of pathological gambling.","volume":"19","author":"Grant","year":"2003","journal-title":"J Gambl Stud"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2005.07.027","article-title":"Stroop performance in pathological gamblers.","volume":"142","author":"Kertzman","year":"2006","journal-title":"Psychiatry Res"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2004.10.003","article-title":"Decision-making impairments in patients wtih pathological gambling.","volume":"133","author":"Brand","year":"2005","journal-title":"Psychiatry Res"},{"key":"R26-11-20210128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/070674370304800105","article-title":"Are there cognitive and behavioural approaches specific to the treatment of pathological gambling?","volume":"48","author":"Tavares","year":"2003","journal-title":"Can J Psychiatry"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1037\/0022-006X.74.3.555","article-title":"Cognitive-behavioral therapy for pathological gamblers.","volume":"74","author":"Petry","year":"2006","journal-title":"J Consult Clin Psychol"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/appi.ajp.163.2.297","article-title":"Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys.","volume":"163","author":"Slutske","year":"2006","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200712000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:36:42Z","timestamp":1618277802000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200712000-00011"}},"subtitle":["A Primary Outcome Study"],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31815a4400","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}